forecast
Vaccine likely in 2021 but uptake delays normalcy to 2022
A successful vaccine trial is likely in the first quarter of 2021 with over 130 efforts across 10 approaches, but a rushed vaccine may have a poor safety profile, and manufacturing, distribution requiring a refrigerated cold chain, and public acceptance will push widespread availability to late 2021 and the turning point to 2022, after which only about 10% are infected and roughly 40-45% may need infection for herd immunity.
forecastpending
Speaker
Nicholas ChristakisEvidence Quote
“even if we invent a vaccine we then have to manufacture it which is not trivial distribute it which is not trivial we need to maintain something known as a cold chain... and finally and most importantly we need to have acceptance”
Created: 6/14/2026, 2:18:58 AM
Your notes
Loading notes...